Ajanta Pharma Q4 net up 20% at Rs 84.31 cr

Ajanta Pharma reported 20 per cent rise in standalone net profit to Rs 84.31 crore for the quarter ended March 31, 2015 on robust sales.
The company had posted net profit of Rs 70.09 crore for the January-March period of the previous fiscal, Ajanta Pharma said in a filing to BSE.
Standalone total income of the company also rose to Rs 368.84 crore for the quarter under consideration from Rs 311.05 crore in the year-ago period.
Consolidated net profit of the company stood at Rs 309.86 crore for the financial year ended March 31, 2015 as against Rs 233.88 crore for the year ago period.

Its total income for 2014-15 rose to Rs 1,480.56 crore from Rs 1,208.34 crore in 2013-14.
Ajanta Pharma MD Yogesh M Agrawal said: "All our businesses continue to perform in-line with our expectations. We remain committed and focused on existing geographies and therapeutic segments to drive industry growth consistently."
In a separate filing to BSE, the company said Board of Directors have recommended dividend at the rate of Rs 6 per equity share on the face value of Rs 2 each.
Ajanta Pharma scrip was trading at Rs 1,260.05, down 6.23 per cent, on the BSE.